Benzodiazepine Tapering & Deprescribing
in Fort Lauderdale, FL

Why does a safe benzodiazepine taper start with the pharmacology?

Dr. Leeds is an osteopathic physician whose practice is based in Fort Lauderdale and centers on benzodiazepine tapering and psychiatric medication deprescribing. He sees patients throughout Florida by video. This page explains the science that shapes every taper he supervises: what a benzodiazepine does at its receptor, how the brain adapts, why the dose cuts must shrink as the taper goes on, why the taper often moves to diazepam, and what tolerance withdrawal and benzodiazepine-induced neurological dysfunction (BIND) are in receptor terms.

The science matters for a practical reason. A person who has taken alprazolam, clonazepam, lorazepam or a sleep medication such as zolpidem exactly as prescribed for months or years has a nervous system that has reorganized itself around the drug. That reorganization is physical dependence, and physical dependence is not addiction: it is a predictable biological adaptation that happens in people who never took an extra tablet, and it calls for a medical taper rather than a program built around behavior. In fact, understanding the mechanism turns a frightening set of symptoms into a problem with a method.

What does a benzodiazepine actually do at the gamma-aminobutyric acid type A (GABA-A) receptor?

GABA is the main inhibitory chemical messenger in the brain. When it binds to the GABA-A receptor, a channel in the nerve cell membrane opens, chloride ions flow in, and the cell becomes harder to fire.

Interestingly, a benzodiazepine does not open that channel by itself. It binds to its own site on the GABA-A receptor and makes the receptor respond more strongly to the GABA that is already there, so each GABA signal produces a larger flow of chloride. Pharmacologists call this positive allosteric modulation. In plain terms, the drug turns up the volume on the brain’s own brake. Additionally, the z-drugs zolpidem, eszopiclone and zaleplon act at the same site on the same receptor, which is why they produce the same kind of dependence and are tapered the same way.

How does the brain adapt, and why does that make stopping suddenly dangerous?

Over weeks and months the brain compensates for the stronger brake, so that the balance between inhibition and excitation drifts back toward normal while the drug is present. The adaptation is thought to involve a blunted response of the GABA-A receptor to the drug, often described as downregulation, in which the benzodiazepine site becomes partly uncoupled from the receptor it sits on, together with a compensating rise in excitatory signaling. The Maudsley Deprescribing Guidelines describe this as a homeostatic response, a new set point: the nervous system has adapted to the drug and now works in its presence.

Unfortunately, those adaptations take far longer to fade than the drug takes to leave the body. When the dose is cut sharply or stopped, the drug is cleared within days or weeks, depending on its half-life, but the compensation remains and for a time operates unopposed: too little inhibition, too much excitation. That mismatch is the withdrawal syndrome, from anxiety, insomnia, tremor and sensory hypersensitivity through to seizures at the extreme. In fact, in 2020 the U.S. Food and Drug Administration (FDA) updated the boxed warning on the labels of all benzodiazepines to state that stopping suddenly or reducing the dose too fast can cause withdrawal reactions that are life threatening, and that withdrawal symptoms can continue for months.

After about four weeks of regular use, a benzodiazepine should never be stopped suddenly. A seizure or any other medical emergency is a 911 call, and anyone who has thoughts of suicide during withdrawal should call or text 988, the Suicide and Crisis Lifeline.

Why do the dose cuts have to get smaller as the taper goes on?

The answer is the shape of the curve that links dose to receptor occupancy, which is not a straight line but a hyperbola. When little drug is present, most receptors are free, so each added unit of drug produces a large change in effect. Yet, as the dose rises, the receptors fill up and each added unit does less, until the curve flattens out. Run that curve backwards and it describes a taper: at a high dose, cutting a fixed amount removes drug that was doing little, so the receptor hardly notices, while near the end the same fixed cut removes a large fraction of the drug’s remaining action, and the nervous system notices a great deal. That is the whole problem of the last stretch.

This is why a linear taper, the same number of milligrams off at every step, tends to go smoothly at first and then come apart near the end, a pattern many people who contact the practice from Fort Lauderdale recognize from an earlier attempt. The Maudsley Deprescribing Guidelines set out the alternative, hyperbolic tapering: each step removes about the same amount of effect at the receptor, so the steps shrink in milligrams as the dose falls, and the last dose before zero is very small. The Ashton Manual, written by Professor C. Heather Ashton from years of clinical work, reaches the same place by a clinical route: its diazepam schedule moves in larger steps from a high dose, then in smaller ones, with the smallest reductions kept for the end.

Fortunately, the principle also says what to do about it. Dr. Leeds builds every taper on it: a taper measured in months, often a year to 18 months or longer, at a pace that bends to the patient’s response.

Why does the taper so often move to diazepam?

Half-life shapes a taper too. Alprazolam and lorazepam are cleared from the body quickly, so the blood level, and with it receptor occupancy, climbs after each dose and falls well before the next one. Even on an unchanged prescription, you can pass through a small withdrawal several times a day, the interdose withdrawal that shows up as early-morning anxiety or a sense of the medication wearing off. So, cutting the dose of a short-acting drug makes each of those daily dips deeper.

Diazepam differs in two ways that matter: it and its active breakdown products stay in the body for a long time, so the blood level is nearly flat across the day, and a reduction produces a slow, even decline in receptor occupancy rather than a cliff. And, it comes in low-strength tablets and in a manufactured liquid, which makes the tiny late-taper steps possible. Those two properties are the rationale for the crossover described in the Ashton Manual, in which the short-acting drug is replaced in stages by an equivalent amount of diazepam, largely before the reduction proper begins. Of course, how a crossover is staged, and when it is better left undone, are decisions for a consultation, and the West Palm Beach page on the Ashton crossover sets out the staging step by step.

What are tolerance withdrawal and BIND in receptor terms?

Tolerance withdrawal is what happens when the adaptation outruns the prescription. The dose has not changed and the tablets are taken on time, yet withdrawal symptoms appear, because the receptor’s response has drifted down far enough that the usual dose no longer offsets the compensation. Unfortunately, it is often mistaken for the original anxiety coming back, and a dose raised on that mistaken diagnosis can steady things for a while as the adaptation deepens. What tolerance withdrawal and BIND feel like week to week is described on the Hollywood page about the patient’s side of a taper.

BIND, benzodiazepine-induced neurological dysfunction, is the term for the neurological symptoms these receptor changes can cause on a steady dose, during a taper, and after it. Tolerance withdrawal is one part of it, and symptoms that last for months after the last dose are called protracted withdrawal. The mechanism is not fully understood. However, the working explanation is that the adaptive changes in GABA-A receptor function and the systems tied to it are slow or incomplete in reversing, so the mismatch that drives withdrawal outlasts the drug. Fortunately, a slow, hyperbolic taper is believed to lower the risk, and the practice’s BIND page covers the condition in depth.

How does the receptor curve turn into prescriptions a Fort Lauderdale pharmacy can fill?

Hyperbolic steps eventually fall below anything a tablet can deliver. A scored diazepam tablet can be halved, perhaps quartered, and then the arithmetic runs out while the curve still calls for smaller cuts. The manufactured diazepam oral solution, 1 milligram per milliliter (1 mg/mL), solves that: measured with an oral syringe, it allows reductions of a fraction of a milligram. It is rarely on the shelf. Still, chain and independent pharmacies across Fort Lauderdale and the rest of Broward County can order it.

On that solution Dr. Leeds continues the taper below 0.5 mg and stops at about 0.1 mg, and he generally reduces the evening dose last. Of course, a small physician-guided increase in dose, when a cut has clearly overshot, is a legitimate adjustment rather than a failure.

When a patient tapers a benzodiazepine other than diazepam, or needs a custom strength, a Florida compounding pharmacy can prepare a liquid or capsules to the exact strength prescribed.

How does care work from Fort Lauderdale, the practice’s home city?

Fort Lauderdale is the Broward County seat and the home of the practice. The office is at 3290 NE 33rd Street, Fort Lauderdale, FL 33308. The office takes calls Monday to Friday, 10 AM to 2 PM. Because the office is here, in-office visits can be arranged now and then during care, while the weekly appointments themselves are usually by secure video from home.

The concierge telemedicine model is the same whether a patient lives in a condominium on the Galt Ocean Mile, a house off Las Olas Boulevard, or a neighborhood west of Interstate 95. Every patient sees Dr. Leeds at every visit, with no hand-off to other practitioners. Each patient has a weekly video appointment, often up to an hour, and 24/7 text access for urgent questions between visits, so that a dose decision is made against how the patient feels this week. A family member the patient invites is welcome to sit in on a video visit.

Everything begins with the contact form. The office then arranges a consultation. The same arrangement reaches the neighboring cities unchanged: Oakland Park, Wilton Manors and Lauderdale-by-the-Sea close by, Pompano Beach beyond them, Plantation, Sunrise and Davie to the west, and Hollywood and Dania Beach to the south.

What situations commonly lead someone in Fort Lauderdale to a taper?

The situations that bring someone to a taper are familiar. Many people have a prescription for alprazolam or clonazepam that began years ago, often with a physician who has since retired or moved, and that grew while the original problem did not shrink. Others started a sleep medication during a hard season of work and never stopped. Some had a new prescriber refuse to continue the medication, or halve it at a single visit, and lived through the frightening weeks that followed. A steady dose that has quietly stopped working is tolerance withdrawal by another name. Or, there was an earlier taper, linear and well meant, that collapsed in its final stretch for exactly the reason the receptor curve predicts.

What else does Dr. Leeds treat, and in what order?

Benzodiazepine and z-drug tapering is the first and largest part of the practice, and the benzodiazepine dependence and tapering service page describes it in full. Dr. Leeds also sits on the medical advisory board of the Benzodiazepine Information Coalition (BIC), a nonprofit that educates patients and prescribers about the harm benzodiazepines can do when taken as prescribed.

Psychiatric medication deprescribing comes second and follows the Maudsley Deprescribing Guidelines: selective serotonin reuptake inhibitors (SSRIs), serotonin and norepinephrine reuptake inhibitors (SNRIs), and gabapentinoids such as gabapentin and pregabalin, tapered one medication at a time, with antipsychotics such as quetiapine tapered in a similar way. To be clear, gabapentinoids are not something Dr. Leeds typically adds to make a benzodiazepine or psychiatric drug taper easier. As a rule he avoids starting any new medication that will one day need a taper of its own, and the psychiatric drug tapering hub takes each of these medications in turn.

Buprenorphine treatment for opioid dependence comes third, as a secondary service: Suboxone, ZubSolv or buprenorphine without naloxone, with monthly visits and weekly ones when needed. Fourth is alcohol treatment with the Sinclair Method: naltrexone taken about an hour before drinking, so that over weeks and months the reward from alcohol fades and the urge to drink fades with it, and abstinence is not required to begin. Low dose naltrexone (LDN), prepared by a compounding pharmacy, is also available for autoimmune-related pain conditions. Other substance problems can be discussed at a consultation, and for someone outside Florida, a consultation may still be possible.

Frequently asked questions

Why do the dose cuts get smaller as a benzodiazepine taper goes on?

Because the link between dose and receptor occupancy is a curve, not a line. At a high dose much of the drug is surplus at the receptor, so a cut is barely felt. Yet, at a low dose nearly every milligram is doing work, so the same cut removes a large share of the effect. Hyperbolic tapering sizes each step so that it removes about the same amount of effect at the receptor, which is why the steps shrink in milligrams toward the end. Cutting a set proportion of the current dose is a common practical way to approximate that.

Why does Dr. Leeds sometimes move a patient from alprazolam or clonazepam to diazepam?

Diazepam’s long half-life gives a steady blood level across the day, so each reduction is a gentle slope rather than a repeated daily drop, and its low-strength tablets and 1 mg/mL oral solution make very small steps practical. Not every patient needs a crossover, and whether one makes sense is decided at the consultation.

What is tolerance withdrawal, and how is it told apart from the original anxiety?

Tolerance withdrawal is withdrawal on a steady dose: the receptor’s response has drifted down past what the usual dose can offset, so symptoms appear between doses. Symptoms that track the dosing clock, that began or worsened on an unchanged dose, and that include things the original anxiety never did, such as sensory hypersensitivity or muscle symptoms, point to tolerance rather than the old condition returning. The sound response is a planned taper. Any change in dose first, to reach stability, is decided case by case with a physician who knows benzodiazepine withdrawal.

Does a patient in Fort Lauderdale have to come to the office?

No. The weekly appointments are by secure video from home. An in-office visit can be arranged at the start or at any point in the taper, but it is never required.

Where is the office, and when does it take calls?

The office is at 3290 NE 33rd Street, Fort Lauderdale, FL 33308. The office takes calls Monday to Friday, 10 AM to 2 PM, and in-office visits are by appointment, arranged through the contact form like everything else.

What should a Fort Lauderdale patient do if the pharmacy cannot fill a taper dose?

Use the 24/7 text line rather than improvising. Stretching the interval between doses or skipping one to make a supply last turns a planned hyperbolic step into an abrupt one, which is exactly what the taper is built to avoid. The prescription can be redirected to another pharmacy in Broward County that will order the solution, or to a compounding pharmacy.

People in Fort Lauderdale and across Broward County who want a taper designed around how their own nervous system will respond can start with the contact form. A consultation follows from there. Contact the office today.

This article is educational. It is not medical advice, and reading it does not create a doctor-patient relationship. Decisions about starting, continuing, or tapering any medication should be made with your own physician.